XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cash, cash equivalents, and short-term marketable securities (Tables)
9 Months Ended
Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Schedule of Restricted Cash
The following table summarizes the Company's cash, cash equivalents, and restricted cash as of September 30, 2022 and 2021.
Nine Months Ended
September 30, 2022
Nine Months Ended
September 30, 2021
(in thousands)Beginning
of period
End
of period
Beginning
of period
End
of period
Cash and cash equivalents$177,947 $184,082 $255,094 $191,707 
Restricted cash included in other assets, noncurrent478 478 321 478 
Total cash, cash equivalents and restricted cash per statement of cash flows$178,425 $184,560 $255,415 $192,185 
Debt Securities, Available-for-Sale The following table summarizes the Company's marketable securities held at September 30, 2022. The Company had no marketable securities as of December 31, 2021.
September 30, 2022
(in thousands)Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Marketable securities
U.S. treasury securities$101,342 $$(228)$101,118 
U.S. government agency securities$4,933 $— $(7)$4,926